First Half FY25 Business Update
Filed with ASX · · 2 pages · English
Summary by 6ix AI
Control Bionics Ltd. has released its first half business update for the fiscal year, highlighting strong growth in the US market. The company anticipates that US revenue for the first half will exceed the previous year's figures significantly, driven by increased demand and new sales opportunities. Despite challenges with Australian NDIS approvals, the company expects encouraging revenue trends in Australia as well. Operational initiatives include cost reductions in the US and the establishment of demonstration sites for their new technology.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Control Bionics
- Expansion into US Sports and Japanese Rehab Markets
- Coffee Microcaps Meeting Presentation
- Significant increase in revenue from faster NDIS approvals
- Addendum to notice of 2024 AGM
- Placement
Later from Control Bionics
- Private Placement
- FY25 Trading Update and NeuroStrip Progress
- Non-Renounceable Rights Issue
- Preliminary Final Report
- Rights Issue Offer Booklet
Follow Control Bionics into a list and get an email when it puts out news.
Follow Control Bionics